Case report: Successful treatment of refractory immune thrombocytopenia in chronic lymphocytic leukaemia with venetoclax monotherapy

In chronic lymphocytic leukaemia (CLL), immune dysregulation is common and can manifest as immune thrombocytopenia (ITP). Corticosteroids are the mainstay for front-line management of CLL-associated ITP. Therapy refractoriness represents a clinical challenge and is an indication to commence CLL-dire...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Timothy Woo, Matthew Carter, George Follows, Piers EM. Patten
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-10-01
Subjects:	chronic lymphocytic leukaemia immune thrombocytopenia refractory venetoclax monotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1260003/full